BioMEdiTech (www.biomeditech.fi), Tampere, Finland Human embryonic (hESC)and recently human induced pluripotent stem cells (hIPSC) provide means to produce most human cell types and moreover hiPSC provide means to get patient specific cells and tissues. Our objective is to develop novel methods to produce and assess functional neuronal cells and cardiomyocytes from human stem cells. These cells are urgently needed to treat neurological disorders, traumas and cardiac failure in humans. Moreover, these cells offer a completely new opportunities for disease and drug discovery platforms for personalized therapy. Hence, new approaches to produce functional cells and moreover methods to analyse the functionality of the cells are well warranted. Bioelectric measurements offer a label free non-invasive way to assess the functionality of neuronal cells and cardiomyocytes. In vitro cultivation system integrated microelectrode array (MEA) technology allows the measurement of electrical signalling activity at the cell, tissue, and network-level. The electrical activity of cardiomyocytes and neuronal cells can be measured while the cellular network develops in vitro on a growth plate with embedded recording and stimulus electrodes. Moreover, we have investigated and assembled biomimetic cell culture environments with integrated biomaterials, microfluidics of medium exchange, pH, oxygen, temperature measurements into the in vitro microelectrode arrays, producing multimodal biomimetic active platform for stem cell differentiation and functional assessment and developed tools. Using these environments proof of the hESC derived active neuronal networks and hiPSC derived cardiomyocytes with patient specific ion channels mutations were investigated. Our next goal is to investigate ways to expand the technology to three dimensional bioelectric culturing environments with multi-type of cells in controlled 3D culture system. For example, in a new FP7 FETOpen project 3DNeuroN, the technology is expanded to 3D neuronal cultures featuring glia and neuronal cells with layered structure of human brain integrated with novel 3D MEA electrode scheme providing new window for neuronal and brain development and ICT interaction.
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